| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.041 | 0.8 |